Search Results

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through GPCR Ecosystem We unite the GPCR community to advance drug discovery. We bring the GPCR community together to fuel GPCR drug discovery—one receptor at a time. Contact Us Our Mission Advance GPCR science and drug discovery by connecting people, data, and opportunities across the global GPCR ecosystem.

function The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets, yet no approved drugs exist for the Adhesion G Protein-coupled receptors (aGPCRs drug discovery methods. This tailored system aims to expedite the identification of drugs targeting the unique aGPCR receptor

Home → Flash News → 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Courses 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. That’s exactly what Terry’s Corner delivers this week: a deep dive into molecular creativity, rational design

Master irreversible kinetics, target depletion, and structured tissue penetration in real drug discovery Home → Flash News → irreversible drugs post 3 Irreversible kinetics = strategic lever in drug design. These lessons bridge molecular pharmacology with real-world design strategy, giving discovery teams the Quantifying irreversible activity (K_inact / K_I) — turning persistent binding into measurable design GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Kinetics #ReceptorPharmacology #MedicinalChemistry

Drugs” closes March 18th! If you’re working on GPCR drug discovery, you know that finding a promising candidate is just the start 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. If you’re working on GPCR drug discovery , you know that finding a promising candidate is just the start 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr.

Home: About Accelerating GPCR Drug Discovery, Together Dr. GPCR is the global hub where academia and industry meet to advance GPCR research, accelerate drug discovery Mastery Flexible, career-ready courses designed by scientists for scientists. the GPCR field through shared knowledge, collaboration, and open access to tools that accelerate drug field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery virtual drug screening to identify agonists and antagonists targeting Class A GPCRs.

Applying Pharmacology to Drug Discovery Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive course library covering cutting-edge GPCR science ✅ Practical insights for real-world drug discovery Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive course library covering cutting-edge GPCR science✅ Practical insights for real-world drug discovery

Discover how low-offset kinetics reshape drug efficacy. Home → Flash News → irreversible drugs post 1 Irreversible Drugs – Trailer Published on October 21, 2025 Category Terry's Corner Irreversible drugs change the rules of engagement. GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #MedicinalChemistry #PKPD #ReceptorKinetics

Measuring and understanding bias helps design drugs that maximize therapeutic benefits while minimizing Kinetics to Candidate Design Lecture 4: Unconventional GPCR Ligands as Drugs Lecture 5: Unique Exploitable Lecture 1: GPCR Project Initiation and Design for Discovery of New Molecules Lecture 2: Drug Affinity GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as

GPCR Podcast Strategic Partners Empowering Drug Discovery for the GPCR Community with Dr. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Review on Apple Podcasts ★ Rate on Spotify ✉️ Send feedback to the team Recent Podcast Articles How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening to this podcast episode

Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development —and registration closes in 3 days! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Previous Next Recent Articles

Week in GPCRs Read Full Issue November 14 - 20, 2025 Crafting Chemical Keys for GPCR Drug Discovery GPCR Read Full Issue Oct 24 - Nov 6, 2025 The Power and Peril of Irreversible Drugs Read Full Issue Oct 17 - 23, 2025 Enzyme Insight, Real-World Impact Read Full Issue Oct 10 - 16, 2025 Design Assays That research and drug discovery. field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather

GPCR Podcast Strategic Partners Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar Ilana Kotliar , his former graduate student, to explore the development of powerful multiplex tools designed , GPCR drug discovery , GPCR online course Summary created by AI ________ About Tom Sakmar Tom Sakmar is a physician-scientist and Rockefeller University professor dedicated to drug discovery and chemical He and his artist/designer wife, Karina Åberg, have three teenage children.

Home → Flash News → 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs GPCR Courses 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”!

Explore the kinetic principles behind persistent binding and smarter drug design. Home → Flash News → irreversible drugs post 2 Persistent binding ≠ just covalent. Published on October 24, 2025 Category Terry's Corner Why do some inhibitors act long after the drug Binding kinetics are a design variable, as critical as potency or clearance. #GPCR #DrGPCR #Pharmacology #DrugDiscovery #BindingKinetics #ReceptorPharmacology #MedicinalChemistry

Principles of Pharmacology in Drug Discovery II Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Principles of Pharmacology in Drug Discovery I Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the on GPCRs. biology and for the identification of drug targets and future drug development.

GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before Stay ahead of the curve with expert-led programs designed for real-world biotech challenges. → Explore innovators and showcase your expertise Training & Upskilling Specialized, insight-packed courses designed

GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to GPCR Courses 🚨 Exciting Opportunity for Professionals in Drug Development! GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to

Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs of GPCR Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr Previous Next Recent Articles

Home → Flash News → terrys corner predict drug behavior Published on July 12, 2025 Category Terry's Corner Dive into the logic of drug modeling with Terry Kenakin. Learn to “extend your eyes” and predict complex drug behaviors. 🟢 Browse the full catalog (and expect ✳️ https://www.terrykenakin.com #pharmacology #drugmechanism #kenakin #GPCR #DrGPCR Previous Next Recent

Home → Flash News → terrys corner model drug response Published on July 10, 2025 Category Terry's Corner What if a single experimental snapshot could predict an entire in vivo drug profile in a range of organs discussed. 🟢 Read the full breakdown: ✳️ https://www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology #DrugDiscovery #TerryKenakin #FoundationalScience Previous Next Recent Articles

GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug GPCR Podcast 🎧 Why Does GPCR Location Make All the Difference? GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against GPCRs and other multi-pass transmembrane targets, such as ion channels, remains a significant challenge Several case studies of GPCR and other multi-pass transmembrane targets are presented, including GPRC5D developing highly specific antibodies for complex targets, with implications for overcoming challenges like drug

Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr Previous Next Recent Articles

Explore their innovative GPCR projects, collaborations, and contributions to cutting-edge drug discovery Celtarys News & Updates Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies Choosing the dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug Custom Development Tailored fluorescent probes designed for unique research requirements.

and lateral gateways, unlocking new possibilities for drug discovery. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #gpcr#drgpcr Published on March 17, 2025 Category GPCR Weekly News A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric sites and lateral gateways, unlocking new possibilities for drug GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️ https:// www.ecosystem.drgpcr.com